Absence of activating mutations in the transmembrane domain of the c-erbB-2 protooncogene in human lung cancer
- PMID: 1483946
- PMCID: PMC5918750
- DOI: 10.1111/j.1349-7006.1992.tb02762.x
Absence of activating mutations in the transmembrane domain of the c-erbB-2 protooncogene in human lung cancer
Abstract
The rat neu gene is known to be activated by a point mutation in its predicted transmembrane domain. Overexpression of the human homologue of neu, the c-erbB-2 gene, in human lung cancer has been reported, and a similar activating point mutation has been suggested. Therefore, we tested for possible aberrations of the c-erbB-2 gene in the region of the transmembrane domain in surgical specimens of human primary lung cancer from 190 patients, and also examined 24 metastases and 26 specimens of noncancerous portions of the lung of the same patients. Single-strand conformation polymorphism analysis of polymerase chain reaction products revealed no point mutations in the target domain in any of these specimens.
Similar articles
-
Absence of activating mutations of the RAF1 protooncogene in human lung cancer.Biol Chem Hoppe Seyler. 1994 Oct;375(10):705-9. doi: 10.1515/bchm3.1994.375.10.705. Biol Chem Hoppe Seyler. 1994. PMID: 7888083
-
Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer.Oncogene. 1990 Feb;5(2):237-9. Oncogene. 1990. PMID: 2181382
-
Practical application of fluorescence-based image analyzer for PCR single-stranded conformation polymorphism analysis used in detection of multiple point mutations.PCR Methods Appl. 1993 May;2(4):323-7. doi: 10.1101/gr.2.4.323. PCR Methods Appl. 1993. PMID: 8324506
-
Detection of DNA aberrations in human cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products.Tohoku J Exp Med. 1992 Oct;168(2):247-55. doi: 10.1620/tjem.168.247. Tohoku J Exp Med. 1992. PMID: 1339101
-
How sensitive is PCR-SSCP?Hum Mutat. 1993;2(5):338-46. doi: 10.1002/humu.1380020503. Hum Mutat. 1993. PMID: 8257985 Review.
References
-
- ) Semba , K. , Kamata , NT. , Toyoshima , K. and Yamamoto , T.A v‐ebB‐related proto‐oncogene, c‐erbB‐2, is distinct from the c‐erbB‐1 epidermal growth factor‐receptor gene and is amplified in a human salivary gland adenocarcinoma . Proc. Natl. Acad. Sci. USA , 82 , 6497 – 6501 ( 1985. ). - PMC - PubMed
-
- ) Yamamoto , T. , Ikawa , S. , Akiyama , T. , Semba , K. , Nomura , N. , Miyajima , NN. , Saito , T. and Toyoshima , K.Similarity of protein encoded by the human c‐erb‐B‐2 gene to epidermal growth factor receptor . Nature , 319 , 230 – 234 ( 1986. ). - PubMed
-
- ) Coussens , L. , Yuang‐Feng , T. L. , Liao , Y.‐C , Chen , E. , Gray , A. , McGrath , J. , Seeburg , P. H. , Libermann , T. A. , Schlessinger , J. , Francke , U. , Levinson , A. and Ullrich , A.Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene . Science , 230 , 1132 – 1139 ( 1985. ). - PubMed
-
- ) Slamon , D. J. , Clark , G. M. , Wong , S. G. , Levin , W. J. , Ullrich , A. and McGuire , R. L.Human breast cancer: correlation of relapse and survival with amplification of the erbB‐2/neu oncogene . Science , 235 , 177 – 182 ( 1987. ). - PubMed
-
- ) Venter , D. J. , Tsui , N. L. , Kumarr , S. and Gullick , W. J.Overexpression of the c‐erbB‐ 2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification . Lancet , ii , 69 – 72 ( 1987. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous